Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Truby

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Science Translational Medicine|June 25, 2025
Core-shell microcapsules compatible with routine injection enable prime/boost immunization against malaria with a single shotRomain Guyon, Sören Reinke, Adam Truby, et al.
Vaccine|November 2, 2025
Naturally acquired immune responses to alpha-gal in malaria endemic settings and pre-clinical efficacy testing with R21/MMEkta S Mukhopadhyay, Duncan G Bellamy, Halidou Tinto, et al.
NPJ Vaccines|June 24, 2026
BCG enables protection against malaria through adjuvanting an adenovirus-vectored vaccineSören Reinke, Marta Ulaszewska, Qi Su, et al.
Frontiers in Immunology|June 1, 2026
Bivalent virus-like particles expressing SPECT1 and CSP trigger pre-erythrocytic malaria immunity and protect against transgenic <i>Plasmodium falciparum</i> sporozoite challenge in miceGulbuse Turan, Ekta Mukhopadhyay, Adam Truby, et al.
Nature Communications|May 18, 2021
Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in miceAlexandra J Spencer, Paul F McKay, Sandra Belij-Rammerstorfer, et al.
Iscience|February 16, 2024
Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell cultureXiangmin Lv, Jesse Martin, Heather Hoover, et al.
Ebiomedicine|March 1, 2022
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studiesAlexandra J Spencer, Susan Morris, Marta Ulaszewska, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Science Translational Medicine|June 25, 2025
Core-shell microcapsules compatible with routine injection enable prime/boost immunization against malaria with a single shotRomain Guyon, Sören Reinke, Adam Truby, et al.
Vaccine|November 2, 2025
Naturally acquired immune responses to alpha-gal in malaria endemic settings and pre-clinical efficacy testing with R21/MMEkta S Mukhopadhyay, Duncan G Bellamy, Halidou Tinto, et al.
NPJ Vaccines|June 24, 2026
BCG enables protection against malaria through adjuvanting an adenovirus-vectored vaccineSören Reinke, Marta Ulaszewska, Qi Su, et al.
Frontiers in Immunology|June 1, 2026
Bivalent virus-like particles expressing SPECT1 and CSP trigger pre-erythrocytic malaria immunity and protect against transgenic <i>Plasmodium falciparum</i> sporozoite challenge in miceGulbuse Turan, Ekta Mukhopadhyay, Adam Truby, et al.
Nature Communications|May 18, 2021
Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in miceAlexandra J Spencer, Paul F McKay, Sandra Belij-Rammerstorfer, et al.
Iscience|February 16, 2024
Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell cultureXiangmin Lv, Jesse Martin, Heather Hoover, et al.
Ebiomedicine|March 1, 2022
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studiesAlexandra J Spencer, Susan Morris, Marta Ulaszewska, et al.
Pageof 1